TY  - JOUR
AU  - Medina López, Rafael Antonio
AU  - Rivero Belenchon, Ines
AU  - Mazuecos-Quirós, Javier
AU  - Congregado-Ruíz, Carmen Belén
AU  - Couñago, Felipe
PY  - 2022
DO  - 10.5306/wjco.v13.i1.1
SN  - 2218-4333
UR  - http://hdl.handle.net/10668/21655
T2  - World journal of clinical oncology
AB  - Metastatic renal cell cancer (mRCC) management has undergone a paradigm shift in recent decades. The first revolution came with the emergence of vascular endothelial growth factor inhibitors; there was a second wave with the unprecedented success of...
LA  - en
KW  - Antiangiogenic
KW  - Biomarkers
KW  - Immune checkpoint inhibitors
KW  - Metastatic renal cell carcinoma
KW  - Systemic treatment
KW  - Update
TI  - Update on the treatment of metastatic renal cell carcinoma.
TY  - research article
VL  - 13
ER  -